Objectively Measured Physical Activity and the Risk of Atrial Fibrillation (from the REGARDS Study).


Journal

The American journal of cardiology
ISSN: 1879-1913
Titre abrégé: Am J Cardiol
Pays: United States
ID NLM: 0207277

Informations de publication

Date de publication:
01 08 2020
Historique:
received: 13 03 2020
revised: 25 04 2020
accepted: 05 05 2020
entrez: 12 7 2020
pubmed: 12 7 2020
medline: 8 9 2020
Statut: ppublish

Résumé

The association between objectively measured physical activity and atrial fibrillation (AF) has not been examined. Therefore, we examined the association between moderate and vigorous physical activity (MVPA) with incident AF in 5,147 participants who completed accelerometer assessment for 4 to 7 consecutive days in the REasons for Geographic and Racial Differences in Stroke (REGARDS) study. MVPA was defined as >1,065 counts/minute, and daily mean time spent in MVPA was computed. Incident AF was identified during follow-up by a study-scheduled electrocardiogram and also from self-reported medical history of a physician diagnosis. Logistic regression was used to assess the relation between daily time in MVPA and incident AF. A total of 429 (8.3%) incident AF cases were detected after a median follow-up of 3.5 years following accelerometer assessment. Participants with higher daily time spent in MVPA were less likely to develop AF than those with lower MVPA achievement (Quartile 1 = 12.4%; Quartile 2 = 8.3%; Quartile 3 = 7.1%; Quartile 4 = 5.4%; p-trend <0.001). In a multivariable model adjusted for AF risk factors, the risk of AF decreased with higher levels of daily MVPA (Quartile 1: Ref; Quartile 2: hazard ratio [HR] = 0.77, 95% confidence interval [CI] 0.58 to 1.01; Quartile 3: HR = 0.72, 95% CI 0.53 to 0.98; Quartile 4: HR = 0.62, 95% CI 0.44 to 0.87; p-trend = 0.0056). In conclusion, higher levels of objectively measured daily MVPA are protective against the development of AF suggesting that promotion of MVPA should be encouraged to reduce the risk of AF.

Identifiants

pubmed: 32650902
pii: S0002-9149(20)30479-3
doi: 10.1016/j.amjcard.2020.05.004
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

107-112

Subventions

Organisme : NINDS NIH HHS
ID : U01 NS041588
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS061846
Pays : United States
Organisme : NHLBI NIH HHS
ID : F32 HL134290
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Wesley T O'Neal (WT)

Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia. Electronic address: wesley.oneal@emory.edu.

Aleena Bennett (A)

Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama.

Matthew J Singleton (MJ)

Department of Medicine, Section on Cardiology, Wake Forest School of Medicine, Winston-Salem, North Carolina.

Suzanne E Judd (SE)

Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama.

George Howard (G)

Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama.

Virginia J Howard (VJ)

Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama.

Steven P Hooker (SP)

Exercise Science and Health Promotion Program, School of Nutrition and Health Promotion, Arizona State University, Phoenix, Arizona.

Elsayed Z Soliman (EZ)

Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia; Department of Epidemiology and Prevention, Epidemiological Cardiology Research Center (EPICARE), Wake Forest School of Medicine, Winston-Salem, North Carolina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH